Bendavia Pipeline

Stealth Peptides is initiating a multinational Phase II clinical trial with Bendavia™ focused on ischemia reperfusion injury in patients experiencing acute ST-segment elevation myocardial infarction (STEMI). The Phase II clinical trial is termed EMBRACE-STEMI™ for the Evaluation of the Myocardial effects of Bendavia for reducing Reperfusion injury in patients with Acute Coronary Events — ST-wave Elevation Myocardial Infarction.